Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1280-1290
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1280
Table 1 Baseline characteristics after propensity score matching, n (%)

Group RS (n = 42)
Group LS (n = 42)
P value
Age (yr)163.5 (55-69)65 (57.8-72.3)0.211
Sex1.000
Male32 (76.2)32 (76.2)
Female10 (23.8)10 (23.8)
BMI222.5 (2.03)22.6 (2.41)0.815
COPD8 (19)8 (19)1.000
Hypertension11 (26.2)9 (21.4)0.608
Diabetes mellitus2 (4.8)4 (9.5)0.397
Coronary artery disease1 (2.4)2 (4.8)0.557
ASA Grade0.890
15 (11.9)4 (9.5)
222 (52.4)24 (57.1)
315 (35.7)14 (33.3)
Neoadjuvant therapy received9 (21.4)8 (19)0.786
Distance between tumor and AV (cm)13 (2-5)3 (2.5-4)0.996
Stage0.969
I10 (23.8)10 (23.8)
II16 (38.1)15 (35.7)
III16 (38.1)17 (40.5)